C08CA01 - amlodipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA01 - amlodipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C09DB01 - valsartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C09DB01 - valsartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C09DB01 - valsartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C08CA05 - nifedipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
A02BC05 - esomeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC05 - esomeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC05 - esomeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC02 - pantoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC02 - pantoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC02 - pantoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
C09DA03 - valsartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DA03 - valsartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DB06 - losartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C08CA05 - nifedipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.